Header image.


180N-preclinical (Tromsø) workshop, Feb 2021

The 180N-preclinical workshop was held in Tromsø and online on 15 Feb 2021.

“Helse Nords forskningsmidler” funding granted

Funding application to the “Helse Nords forskningsmidler” for the project “Branching out – Development of radiocopper (Cu-64/Cu-67) radiopharmaceuticals for precision medicine theranostics in glioblastoma vascularization” has been granted. Project leader: Mathias Kranz. Congratulations!